Share on LinkedInShare on LinkedIn

ARTICLE · 26 FEBRUARY 2019

Manufacturing Waiver To Include Stockpiling

J A Kemp
J A Kemp
Contributor
J A Kemp

J A Kemp

J A Kemp is one of the largest European patent and trade mark attorney firms, with offices in...

View firm profile
Explore more from J A Kemp

On 28 May 2018 the European Commission published a proposal for a change in the law which would permit third parties to manufacture a medicinal product protected by a Supplementary Protection Certificate

United KingdomInternational Law

On 28 May 2018 the European Commission published a proposal for a change in the law which would permit third parties to manufacture a medicinal product protected by a Supplementary Protection Certificate (see discussion here and here).

Earlier this month we reported the Council's position for negotiations with the European Parliament (see discussion here and here). The European Parliament published its own position and the negotiators have since met. The outcome was briefly reported in a press statement from the Parliament on 14 February 2019 here. This press statement does not identify how all areas of disagreement were resolved, but does suggest that Parliament negotiators were successful in pressing for the waiver to be extended to stockpiling for day 1 release in the EU. The proposal now moves to Parliament and Council for formal approval.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from